Sargent Investment Group LLC Boosts Stake in Danaher Co. (NYSE:DHR)

Sargent Investment Group LLC increased its stake in Danaher Co. (NYSE:DHR) by 19.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,280 shares of the conglomerate’s stock after acquiring an additional 1,678 shares during the period. Sargent Investment Group LLC’s holdings in Danaher were worth $2,378,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Wellington Management Group LLP grew its holdings in shares of Danaher by 18.6% during the 3rd quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate’s stock valued at $6,185,203,000 after purchasing an additional 3,905,449 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Danaher by 6.5% in the third quarter. Bank of New York Mellon Corp now owns 8,183,501 shares of the conglomerate’s stock worth $2,030,327,000 after buying an additional 502,868 shares during the period. Northern Trust Corp lifted its stake in shares of Danaher by 1.7% in the 3rd quarter. Northern Trust Corp now owns 8,100,722 shares of the conglomerate’s stock valued at $2,009,789,000 after acquiring an additional 134,905 shares during the last quarter. Flossbach Von Storch AG boosted its holdings in Danaher by 1.8% during the 4th quarter. Flossbach Von Storch AG now owns 4,601,351 shares of the conglomerate’s stock valued at $1,064,477,000 after acquiring an additional 82,672 shares during the period. Finally, Invesco Ltd. grew its position in Danaher by 13.2% during the 3rd quarter. Invesco Ltd. now owns 4,070,455 shares of the conglomerate’s stock worth $1,009,880,000 after acquiring an additional 473,693 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent analyst reports. Raymond James boosted their price target on Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Robert W. Baird boosted their target price on Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday. Barclays upped their target price on Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday. TD Cowen lifted their price objective on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, Bank of America lifted their price objective on Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a report on Wednesday. Six investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $269.64.

Danaher Stock Up 0.3 %

Shares of DHR traded up $0.78 during trading hours on Friday, hitting $246.58. The company had a trading volume of 2,710,446 shares, compared to its average volume of 2,710,897. The company’s fifty day moving average price is $248.87 and its two-hundred day moving average price is $231.16. The company has a current ratio of 1.85, a quick ratio of 1.37 and a debt-to-equity ratio of 0.31. Danaher Co. has a one year low of $182.09 and a one year high of $259.00. The company has a market capitalization of $182.64 billion, a PE ratio of 41.79, a price-to-earnings-growth ratio of 3.79 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. During the same period in the previous year, the firm posted $2.36 earnings per share. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. As a group, equities analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were paid a dividend of $0.27 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date was Wednesday, March 27th. Danaher’s dividend payout ratio is presently 18.31%.

Insider Buying and Selling at Danaher

In other news, SVP Georgeann Couchara sold 2,622 shares of Danaher stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total value of $636,280.74. Following the sale, the senior vice president now owns 4,244 shares in the company, valued at $1,029,891.48. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Danaher news, Director Teri List sold 3,289 shares of the business’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total value of $816,724.48. Following the transaction, the director now directly owns 19,726 shares in the company, valued at approximately $4,898,360.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the transaction, the senior vice president now directly owns 4,244 shares in the company, valued at approximately $1,029,891.48. The disclosure for this sale can be found here. Over the last three months, insiders have sold 106,565 shares of company stock valued at $26,641,364. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.